Entrada Therapeutics shares owned by Ubs Global Asset Management Americas
Quarter-by-quarter ownership of Entrada Therapeutics (TRDA) shares owned by Ubs Global Asset Management Americas
from 13F filings
Historical chart of Ubs Global Asset Management Americas investment in Entrada Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Entrada Therapeutics held by Ubs Global Asset Management Americas consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Entrada Therapeutics by Ubs Global Asset Management Americas
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-12-31 | $225 | 22 | 10.27 |
| 2025-09-30 | $643 | 111 | 5.80 |
| 2025-03-31 | $304k | 34k | 9.04 |
| 2024-12-31 | $618k | 36k | 17.29 |
| 2024-09-30 | $226k | 14k | 15.98 |
| 2024-06-30 | $150k | 11k | 14.25 |
More positions owned by Ubs Global Asset Management Americas
View all positions for Ubs Global Asset Management Americas